Target intelligence / Profile preview

Cationic and adsorbable orally administered drugs in the gastrointestinal lumen

Molecular classification
Other
01

Overview

Cationic and adsorbable orally administered drugs in the gastrointestinal lumen refers to a broad pharmacological category of medications that are susceptible to sequestration by non-absorbed binding agents within the digestive tract. This target class primarily includes drugs that possess a positive (cationic) charge or specific physicochemical properties that facilitate their adsorption or ion exchange with therapeutic resins and binders. These drugs are not biological targets in the traditional sense; rather, they represent a group of exogenous substances that can be bound by agents such as patiromer, sodium polystyrene sulfonate, or activated charcoal. When these drugs are co-administered with such binders, they may be trapped in the gastrointestinal lumen, preventing their absorption into the systemic circulation and significantly reducing their therapeutic efficacy. This interaction is a critical clinical consideration, particularly for patients on complex medication regimens, and typically necessitates a dosing separation of several hours to ensure adequate drug bioavailability.

Other names
Positively charged oral medicationsAdsorbable drugs in the GI tractGI-adsorbable drugsCationic medications
02

Mechanism of action

Adsorption, ion exchange, and sequestration within the gastrointestinal tract.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Reduced therapeutic efficacy of co-administered medicationsDrug-drug interactionsRequirement for spaced dosing
06

Interacting drugs

Patiromer

6 more in the full profile.

07

Biomarkers

Drug plasma concentration (Cmax)Area under the curve (AUC) of co-administered drugs

Beyond the preview

Go deeper on Cationic and adsorbable orally administered drugs in the gastrointestinal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cationic and adsorbable orally administered drugs in the gastrointestinal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call